2006
DOI: 10.1016/j.ejphar.2005.11.012
|View full text |Cite
|
Sign up to set email alerts
|

Scratching behavior in mice induced by the proteinase-activated receptor-2 agonist, SLIGRL-NH2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

5
101
0

Year Published

2008
2008
2020
2020

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 109 publications
(106 citation statements)
references
References 15 publications
5
101
0
Order By: Relevance
“…For example, acute topical application of tacrolimus inhibits scratching induced by PAR 2 -activating peptide, but not histamine (29). In this context, scratching induced by SLIGRL-NH 2 , a PAR 2 -activating peptide, is not inhibited by an H 1 histamine-receptor antagonist (7,8), and distinct dorsal horn neurons may receive signals of cutaneous stimulation with PAR 2 -activating peptide and histamine (30). Taking these findings into account, the present results suggest that PAR 2 and tryptase are interesting target molecules for the development of novel drugs effective against anti-histamine-resistant pruritus, like that in atopic dermatitis.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…For example, acute topical application of tacrolimus inhibits scratching induced by PAR 2 -activating peptide, but not histamine (29). In this context, scratching induced by SLIGRL-NH 2 , a PAR 2 -activating peptide, is not inhibited by an H 1 histamine-receptor antagonist (7,8), and distinct dorsal horn neurons may receive signals of cutaneous stimulation with PAR 2 -activating peptide and histamine (30). Taking these findings into account, the present results suggest that PAR 2 and tryptase are interesting target molecules for the development of novel drugs effective against anti-histamine-resistant pruritus, like that in atopic dermatitis.…”
Section: Discussionmentioning
confidence: 99%
“…Intradermal injection of PAR 2 -activating peptide elicits scratching in mice (7,8). Activating peptides of PAR 1 and PAR 4 , but not PAR 3 , also elicit scratching, but scratching induced by PAR 1 -and PAR 4 -activating, but not PAR 2 -activating, peptides is inhibited by an H 1 histamine-receptor antagonist, suggesting that PAR 1 -and PAR 4 -associated scratching involves histamine release from mast cells (8).…”
Section: Introductionmentioning
confidence: 99%
“…In marked contrast, the identical application of cowhage spicules, as well as intradermal injection of PAR-2 and -4 agonists, elicited robust scratching in mice (Akiyama et al 2009c(Akiyama et al , 2010bShimada et al 2006;Tsujii et al 2009). Cowhage spicules contain mucunain, which acts via PAR-2 and PAR-4 to elicit itch in humans (Reddy et al 2008).…”
Section: Discussionmentioning
confidence: 99%
“…As mentioned above, some evidence suggests the involvement of PAR 2 in itch, but the involvement of the other PARs remains unknown. Thus, the present study was conducted to compare the itchinducing efficacy of selective agonists of PAR [1][2][3][4] and determine the involvement of histamine.…”
mentioning
confidence: 99%
“…Recently, proteinase-activated receptor 2 (PAR 2 ) has been shown to be involved in itch. PAR 2 -activating peptide (PAR 2 -AP) provokes itch in the skin, especially atopic eczema, in humans (3) and it elicits scratching in mice (4). Tryptase, a PAR 2 agonist proteinase, induces scratching in mice, which is inhibited by anti-PAR 2 antibody and the PAR 2 antagonist FSLLRY-NH 2 (5).…”
mentioning
confidence: 99%